0001127602-22-028082.txt : 20221221 0001127602-22-028082.hdr.sgml : 20221221 20221221164102 ACCESSION NUMBER: 0001127602-22-028082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221219 FILED AS OF DATE: 20221221 DATE AS OF CHANGE: 20221221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thackray Helen M. CENTRAL INDEX KEY: 0001589725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 221478879 MAIL ADDRESS: STREET 1: C/O GLYCOMIMETICS, INC. STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-12-19 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001589725 Thackray Helen M. 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 1 Chief R&D Officer Common Stock 2022-12-19 4 A 0 81000 0 A 214275 D Emp. Stock Option (Right to Buy) 10.63 2022-12-19 4 A 0 238000 0 A 2023-12-19 2032-12-19 Common Stock 238000 238000 D Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. /s/ Alane P. Barnes, by power of attorney 2022-12-21